These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21481691)

  • 1. A cytomegalovirus vaccine tames the troll of transplantation.
    Schleiss MR
    Lancet; 2011 Apr; 377(9773):1216-8. PubMed ID: 21481691
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
    Gondo H
    Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.
    Griffiths PD; Stanton A; McCarrell E; Smith C; Osman M; Harber M; Davenport A; Jones G; Wheeler DC; O'Beirne J; Thorburn D; Patch D; Atkinson CE; Pichon S; Sweny P; Lanzman M; Woodford E; Rothwell E; Old N; Kinyanjui R; Haque T; Atabani S; Luck S; Prideaux S; Milne RS; Emery VC; Burroughs AK
    Lancet; 2011 Apr; 377(9773):1256-63. PubMed ID: 21481708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT
    Lancet Infect Dis; 2012 Apr; 12(4):290-9. PubMed ID: 22237175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytomegalovirus vaccine for transplantation: are we closer?
    Go V; Pollard RB
    J Infect Dis; 2008 Jun; 197(12):1631-3. PubMed ID: 18444884
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antigenemia test for cytomegalovirus].
    Pérez JL; Salvà J; Niubó J
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):251-61. PubMed ID: 8049289
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus Triplex vaccine in pediatric hematopoietic stem cell transplant patients at high risk for cytomegalovirus complications: evaluation of vaccine safety, immunogenicity and impact on viremia requiring antivirals.
    La Rosa C; Park Y; Yang D; Zhou Q; Kaltcheva T; Karras N; Cheng J; Sun W; Diamond DJ; Pawlowska A
    Haematologica; 2024 Jul; 109(7):2303-2308. PubMed ID: 38426277
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
    Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection following stem cell transplantation.
    Einsele H; Hebart H
    Haematologica; 1999 Jun; 84 Suppl EHA-4():46-9. PubMed ID: 10907466
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia.
    Lisboa LF; Kumar D; Wilson LE; Humar A
    Transplantation; 2012 Jan; 93(2):195-200. PubMed ID: 22179399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus prophylaxis strategies in high-risk transplantation.
    Snydman DR
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):20-2. PubMed ID: 7940971
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the biologic basis of late-onset cytomegalovirus disease in high-risk organ transplant recipients.
    Singh N
    Transplantation; 2011 Apr; 91(8):825-6. PubMed ID: 21372754
    [No Abstract]   [Full Text] [Related]  

  • 15. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
    Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
    Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against the human cytomegalovirus.
    Plotkin SA; Boppana SB
    Vaccine; 2019 Nov; 37(50):7437-7442. PubMed ID: 29622379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus vaccine: timing is important.
    Griffiths PD
    Rev Med Virol; 2018 Jul; 28(4):e1986. PubMed ID: 29921027
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.